CA Stock MarketDetailed Quotes

FRX Fennec Pharmaceuticals Inc

Watchlist
  • 8.930
  • +0.020+0.22%
15min DelayMarket Closed Dec 24 13:00 ET
244.97MMarket Cap-165.37P/E (TTM)

Fennec Pharmaceuticals Inc Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
20.07%-2.21M
-112.54%-8.39M
800.14%39.05M
5.07%-17.14M
28.55%-4.86M
44.91%-2.76M
-16.40%-3.95M
-95.27%-5.58M
-26.97%-18.06M
-109.61%-6.8M
Net income from continuing operations
-207.18%-5.74M
-2.00%-5.55M
312.11%12.84M
32.34%-16.05M
60.89%-2.68M
76.92%-1.87M
-7.33%-5.44M
-63.74%-6.05M
-36.71%-23.71M
-54.89%-6.86M
Depreciation and amortization
--25K
150.00%26K
1,290.38%723K
----
----
--0
---52K
--52K
----
----
Unrealized gains and losses of investment securities
----
---11K
-63.33%11K
-78.80%39K
----
----
--0
-67.03%30K
636.00%184K
-64.20%58K
Remuneration paid in stock
110.52%1.82M
-63.63%925K
9.37%1.19M
31.00%5.35M
3.63%857K
-53.32%865K
152.28%2.54M
172.93%1.09M
9.02%4.09M
-10.01%827K
Other non cashItems
-57.58%336K
242.40%428K
1,990.00%418K
1.77%287K
-750.00%-650K
708.16%792K
190.70%125K
-51.22%20K
0.00%282K
-62.26%100K
Change In working capital
-9.64%-2.76M
-276.83%-4.21M
3,433.38%23.87M
-714.51%-6.78M
-160.65%-2.42M
-328.88%-2.52M
-279.45%-1.12M
-331.72%-716K
218.35%1.1M
-467.07%-930K
-Change in receivables
-101.92%-4.2M
-167.45%-2.04M
-957.97%-1.46M
-370.49%-7.27M
-177.61%-4.29M
---2.08M
---762K
---138K
---1.55M
---1.55M
-Change in inventory
258.86%502K
84.64%-80K
126.90%92K
-174.31%-1.58M
30.38%-401K
---316K
---521K
---342K
---576K
---576K
-Change in prepaid assets
525.24%1.31M
-40.11%109K
-1,560.31%-1.91M
-60.61%104K
14.84%-419K
-0.94%210K
-19.11%182K
-58.93%131K
211.39%264K
-348.48%-492K
-Change in payables and accrued expense
8.68%-305K
-12,147.06%-2.08M
654.50%2.04M
-33.51%1.96M
59.55%2.68M
-137.53%-334K
-104.24%-17K
-1,938.89%-367K
526.26%2.95M
566.94%1.68M
-Change in other current assets
--364K
---122K
---133K
-50.00%3K
50.00%3K
--0
--0
--0
400.00%6K
200.00%2K
-Change in other current liabilities
---437K
--0
--25.25M
----
----
--0
--0
--0
----
----
Cash from discontinued investing activities
Operating cash flow
20.07%-2.21M
-112.54%-8.39M
800.14%39.05M
5.07%-17.14M
28.55%-4.86M
44.91%-2.76M
-16.40%-3.95M
-95.27%-5.58M
-26.97%-18.06M
-109.61%-6.8M
Investing cash flow
Cash flow from continuing investing activities
Cash from discontinued investing activities
Financing cash flow
Cash flow from continuing financing activities
-362.69%-528K
-50.00%257K
-686.53%-1.13M
-67.98%6.64M
595.39%5.73M
-98.99%201K
1,017.39%514K
1,186.67%193K
316.47%20.73M
8,140.00%824K
Net issuance payments of debt
----
----
----
-74.93%5M
----
----
----
----
298.70%19.94M
---65K
Proceeds from stock option exercised by employees
-318.60%-470K
-35.86%347K
194.37%627K
84.91%1.72M
10.01%747K
14.36%215K
1,076.09%541K
1,320.00%213K
2,712.12%928K
7,444.44%679K
Net other financing activities
-314.29%-58K
-233.33%-90K
-8,695.00%-1.76M
42.75%-75K
-106.67%-14K
---14K
---27K
---20K
-138.18%-131K
20,900.00%210K
Cash from discontinued financing activities
Financing cash flow
-362.69%-528K
-50.00%257K
-686.53%-1.13M
-67.98%6.64M
595.39%5.73M
-98.99%201K
1,017.39%514K
1,186.67%193K
316.47%20.73M
8,140.00%824K
Net cash flow
Beginning cash position
187.83%43.05M
178.33%51.18M
-44.19%13.27M
12.67%23.77M
-58.33%12.4M
0.29%14.96M
0.72%18.39M
12.67%23.77M
-30.46%21.1M
22.26%29.75M
Current changes in cash
-6.84%-2.73M
-136.89%-8.13M
804.22%37.92M
-492.86%-10.51M
114.55%870K
-117.25%-2.56M
-2.63%-3.43M
-89.51%-5.38M
128.93%2.67M
-84.79%-5.98M
End cash Position
225.19%40.32M
187.83%43.05M
178.33%51.18M
-44.19%13.27M
-44.19%13.27M
-58.33%12.4M
0.29%14.96M
0.72%18.39M
12.67%23.77M
12.67%23.77M
Free cash from
20.07%-2.21M
-112.54%-8.39M
800.14%39.05M
5.07%-17.14M
28.55%-4.86M
44.91%-2.76M
-16.40%-3.95M
-95.27%-5.58M
-26.97%-18.06M
-109.61%-6.8M
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
--
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 20.07%-2.21M-112.54%-8.39M800.14%39.05M5.07%-17.14M28.55%-4.86M44.91%-2.76M-16.40%-3.95M-95.27%-5.58M-26.97%-18.06M-109.61%-6.8M
Net income from continuing operations -207.18%-5.74M-2.00%-5.55M312.11%12.84M32.34%-16.05M60.89%-2.68M76.92%-1.87M-7.33%-5.44M-63.74%-6.05M-36.71%-23.71M-54.89%-6.86M
Depreciation and amortization --25K150.00%26K1,290.38%723K----------0---52K--52K--------
Unrealized gains and losses of investment securities -------11K-63.33%11K-78.80%39K----------0-67.03%30K636.00%184K-64.20%58K
Remuneration paid in stock 110.52%1.82M-63.63%925K9.37%1.19M31.00%5.35M3.63%857K-53.32%865K152.28%2.54M172.93%1.09M9.02%4.09M-10.01%827K
Other non cashItems -57.58%336K242.40%428K1,990.00%418K1.77%287K-750.00%-650K708.16%792K190.70%125K-51.22%20K0.00%282K-62.26%100K
Change In working capital -9.64%-2.76M-276.83%-4.21M3,433.38%23.87M-714.51%-6.78M-160.65%-2.42M-328.88%-2.52M-279.45%-1.12M-331.72%-716K218.35%1.1M-467.07%-930K
-Change in receivables -101.92%-4.2M-167.45%-2.04M-957.97%-1.46M-370.49%-7.27M-177.61%-4.29M---2.08M---762K---138K---1.55M---1.55M
-Change in inventory 258.86%502K84.64%-80K126.90%92K-174.31%-1.58M30.38%-401K---316K---521K---342K---576K---576K
-Change in prepaid assets 525.24%1.31M-40.11%109K-1,560.31%-1.91M-60.61%104K14.84%-419K-0.94%210K-19.11%182K-58.93%131K211.39%264K-348.48%-492K
-Change in payables and accrued expense 8.68%-305K-12,147.06%-2.08M654.50%2.04M-33.51%1.96M59.55%2.68M-137.53%-334K-104.24%-17K-1,938.89%-367K526.26%2.95M566.94%1.68M
-Change in other current assets --364K---122K---133K-50.00%3K50.00%3K--0--0--0400.00%6K200.00%2K
-Change in other current liabilities ---437K--0--25.25M----------0--0--0--------
Cash from discontinued investing activities
Operating cash flow 20.07%-2.21M-112.54%-8.39M800.14%39.05M5.07%-17.14M28.55%-4.86M44.91%-2.76M-16.40%-3.95M-95.27%-5.58M-26.97%-18.06M-109.61%-6.8M
Investing cash flow
Cash flow from continuing investing activities
Cash from discontinued investing activities
Financing cash flow
Cash flow from continuing financing activities -362.69%-528K-50.00%257K-686.53%-1.13M-67.98%6.64M595.39%5.73M-98.99%201K1,017.39%514K1,186.67%193K316.47%20.73M8,140.00%824K
Net issuance payments of debt -------------74.93%5M----------------298.70%19.94M---65K
Proceeds from stock option exercised by employees -318.60%-470K-35.86%347K194.37%627K84.91%1.72M10.01%747K14.36%215K1,076.09%541K1,320.00%213K2,712.12%928K7,444.44%679K
Net other financing activities -314.29%-58K-233.33%-90K-8,695.00%-1.76M42.75%-75K-106.67%-14K---14K---27K---20K-138.18%-131K20,900.00%210K
Cash from discontinued financing activities
Financing cash flow -362.69%-528K-50.00%257K-686.53%-1.13M-67.98%6.64M595.39%5.73M-98.99%201K1,017.39%514K1,186.67%193K316.47%20.73M8,140.00%824K
Net cash flow
Beginning cash position 187.83%43.05M178.33%51.18M-44.19%13.27M12.67%23.77M-58.33%12.4M0.29%14.96M0.72%18.39M12.67%23.77M-30.46%21.1M22.26%29.75M
Current changes in cash -6.84%-2.73M-136.89%-8.13M804.22%37.92M-492.86%-10.51M114.55%870K-117.25%-2.56M-2.63%-3.43M-89.51%-5.38M128.93%2.67M-84.79%-5.98M
End cash Position 225.19%40.32M187.83%43.05M178.33%51.18M-44.19%13.27M-44.19%13.27M-58.33%12.4M0.29%14.96M0.72%18.39M12.67%23.77M12.67%23.77M
Free cash from 20.07%-2.21M-112.54%-8.39M800.14%39.05M5.07%-17.14M28.55%-4.86M44.91%-2.76M-16.40%-3.95M-95.27%-5.58M-26.97%-18.06M-109.61%-6.8M
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion------------

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Trending CA Stocks
Big Five Big Five

The "Big Five" refers to Canada's five largest banks—Royal Bank of Canada, Toronto-Dominion Bank, Bank of Nova Scotia, Bank of Montreal, and Canadian Imperial Bank of Commerce—which dominate and significantly influence the country's financial sector. The "Big Five" refers to Canada's five largest banks—Royal Bank of Canada, Toronto-Dominion Bank, Bank of Nova Scotia, Bank of Montreal, and Canadian Imperial Bank of Commerce—which dominate and significantly influence the country's financial sector.